276 related articles for article (PubMed ID: 17532764)
61. Soluble transferrin receptor in hemochromatosis patients during phlebotomy therapy.
Piéroni L; Mekhloufi F; Thiolières JM; Hainque B; Herson S; Jardel C
Clin Chim Acta; 2005 Mar; 353(1-2):61-6. PubMed ID: 15698591
[TBL] [Abstract][Full Text] [Related]
62. Expected value of serum soluble transferrin receptor, erythropoietin and ferritin and their correlation among healthy non-anemic Thai children.
Wiwanitkit V; Preechakas P; Bhokaisawan N; Boonchalermvichian C
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S241-5. PubMed ID: 12188418
[TBL] [Abstract][Full Text] [Related]
63. Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels.
R'zik S; Loo M; Beguin Y
Haematologica; 2001 Mar; 86(3):244-51. PubMed ID: 11255270
[TBL] [Abstract][Full Text] [Related]
64. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
65. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
[TBL] [Abstract][Full Text] [Related]
66. Reference limits and behaviour of serum transferrin receptor in children 6-10 years of age.
Danise P; Maconi M; Morelli G; Di Palma A; Rescigno G; Esposito C; Avino D; Talento B
Int J Lab Hematol; 2008 Aug; 30(4):306-11. PubMed ID: 18665828
[TBL] [Abstract][Full Text] [Related]
67. Serum prohepcidin level in myelodysplasia.
El Husseiny NM; Matter MM; Sabry RM; Amin IS
Scand J Clin Lab Invest; 2010 Sep; 70(5):343-6. PubMed ID: 20509758
[TBL] [Abstract][Full Text] [Related]
68. Serum transferrin receptor status of healthy adult Arabs.
Knox-Macaulay H; Gravell D; Elender F
Ann Clin Lab Sci; 2007; 37(1):57-62. PubMed ID: 17311870
[TBL] [Abstract][Full Text] [Related]
69. Serum transferrin receptors: Distribution and diagnostic performance in pre-school children.
Chouliaras GL; Premetis E; Tsiftis G; Drosatou P; Papassotiriou I; Stamoulakatou A; Lycopoulou L
Blood Cells Mol Dis; 2009; 43(2):163-8. PubMed ID: 19394251
[TBL] [Abstract][Full Text] [Related]
70. Nucleolar abnormalities--a defect of the nucleolar preribosome assembly--in ringed sideroblasts in refractory anaemia with ringed sideroblasts (RARS) of myelodysplastic syndrome (MDS). An electron microscopic study.
Smetana K; Cermák J; Jirásková I; Malasková V
Sb Lek; 2003; 104(2):199-207. PubMed ID: 14577129
[TBL] [Abstract][Full Text] [Related]
71. Accelerated cellular senescence in myelodysplastic syndrome.
Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX
Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
[TBL] [Abstract][Full Text] [Related]
73. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
[TBL] [Abstract][Full Text] [Related]
74. Detection of CD55- and CD59-deficient granulocytic populations in patients with myelodysplastic syndrome.
Kaiafa G; Papadopoulos A; Ntaios G; Saouli Z; Savopoulos C; Tsesmeli N; Kontoninas Z; Chatzinikolaou A; Tsavdaridou V; Klonizakis I; Hatzitolios A
Ann Hematol; 2008 Apr; 87(4):257-62. PubMed ID: 18158579
[TBL] [Abstract][Full Text] [Related]
75. Adequacy of iron supply for erythropoiesis: in vivo observations in humans.
Cazzola M; Pootrakul P; Bergamaschi G; Huebers HA; Eng M; Finch CA
J Lab Clin Med; 1987 Dec; 110(6):734-9. PubMed ID: 3681115
[TBL] [Abstract][Full Text] [Related]
76. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
[TBL] [Abstract][Full Text] [Related]
77. Accuracy of serum transferrin receptor levels in the diagnosis of iron deficiency among hospital patients in a population with a high prevalence of thalassaemia trait.
Ong KH; Tan HL; Tam LP; Hawkins RC; Kuperan P
Int J Lab Hematol; 2008 Dec; 30(6):487-93. PubMed ID: 18983300
[TBL] [Abstract][Full Text] [Related]
78. Ferrokinetic evaluation of erythropoiesis in patients with myelodysplastic syndromes.
Uchida T; Kokubun K; Abe R; Kimura H; Yui T; Matsuda S; Kariyone S
Acta Haematol; 1988; 79(2):81-3. PubMed ID: 3124477
[TBL] [Abstract][Full Text] [Related]
79. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
de Melo Campos P; Traina F; da Silva Santos Duarte A; Lorand-Metze I; Costa FF; Saad ST
Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
[TBL] [Abstract][Full Text] [Related]
80. Serum transferrin receptor levels in patients with thalassemia intermedia during rHuEPO administration.
Dore F; Bonfigli S; Gaviano E; Pardini S; Longinotti M
Haematologica; 1996; 81(1):37-9. PubMed ID: 8900849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
